PTX:ASX
Prescient Therapeutics Ltd
A$0,055
0,00%
(0,00) 1D
20 Nov., 16:00:00 GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PTX...
Open
A$0,06
High
A$0,06
Low
A$0,06
Mkt. cap
62,91 m.
Avg. vol.
417,00 k
Volume
259,60 k
52-wk high
A$0,12
52-wk low
A$0,05
EPS
-A$0,01
Shares outstanding
1,14 mjd.
No. of employees
3
Open
A$0,06
High
A$0,06
Low
A$0,06
Mkt. cap
62,91 m.
Avg. vol.
417,00 k
Volume
259,60 k
52-wk high
A$0,12
52-wk low
A$0,05
EPS
-A$0,01
Shares outstanding
1,14 mjd.
No. of employees
3
News stories
From web sources and news partners
WSJ
·
2 dae gelede
Dow, S&P 500 Poised to Close at a Correction
The Motley Fool
·
8 uur gelede
The S&P 500 Is 14 for 14 After Midterm Elections. Here’s How I’d Invest Now.
Benzinga
·
1 uur gelede
Dow Jones and S&P 500 Outlook: Top Stock Market Headlines and Data This Week
Profile
Prescient Therapeutics is a clinical-stage oncology company developing targeted therapies. Prescient's technologies emanate from prestigious world class centres including Yale, Penn, Oxford and Moffitt. Wikipedia
About Prescient Therapeutics Ltd
CEOSteven Yatomi-Clarke
Employees3
Founded22 Mei 1986
Headquarters-
SectorHealth Care
Industry-
Websiteptxtherapeutics.com